Danziger Asaf - Jan 6, 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Executive Officer, Director
Signature
By: /s/ Steven Robbins, Attorney in Fact for Asaf Danziger
Stock symbol
NVCR
Transactions as of
Jan 6, 2022
Transactions value $
$1,978
Form type
4
Date filed
1/12/2022, 04:31 PM
Previous filing
Nov 29, 2021
Next filing
Mar 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Award $1.98K +31 +0.23% $63.82 13.3K Jan 6, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2021 through December 31, 2021. This transaction is also exempt under Rule 16b-3(c).
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2021.